When your required draw volume exceeds 80 units (0.8 mL), switching to a higher concentration reduces injection volume and improves measurement accuracy
Or you draw 25 units from a 5 mg/mL vial thinking you have your starting dose, but you actually pulled just 1.25 mg, half of what you needed
Patients often notice a reduction in appetite shortly after starting the medication, leading to gradual and steady weight loss
Many people taking tirzepatide may experience body aches, including muscle pain, joint stiffness, or general discomfort
Smooth, sustained metabolic support
However, this coincided with increasing reports of hair loss, leading to the FDA issuing a warning in 2023 that GLP-1 receptor agonists (such as tizepatide) may increase the risk of alopecia